Invasive group A streptococcal infections in adults, France (2006–2010)

Carapetis, 2005, The global burden of group A streptococcal diseases, Lancet Infect Dis, 5, 685, 10.1016/S1473-3099(05)70267-X Lepoutre, 2011, Epidemiology of invasive Streptococcus pyogenes infections in France, 2007, J ClinMicrobiol Bisno, 2003, Molecular basis of group A streptococcal virulence, Lancet Infect Dis, 3, 191, 10.1016/S1473-3099(03)00576-0 Beall, 1996, Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci, J Clin Microbiol, 34, 953, 10.1128/JCM.34.4.953-958.1996 Steer, 2009, Global emm type distribution of group A streptococci: systematic review and implications for vaccine development, Lancet Infect Dis, 9, 611, 10.1016/S1473-3099(09)70178-1 Fraser, 2008, The bacterial superantigen and superantigen-like proteins, Immunol Rev, 225, 226, 10.1111/j.1600-065X.2008.00681.x Norrby-Teglund, 2001, Evidence for superantigen involvement in severe group A streptococcal tissue infections, J Infect Dis, 184, 853, 10.1086/323443 Schmitz, 2003, Toxin-gene profile heterogeneity among endemic invasive European group A streptococcal isolates, J Infect Dis, 188, 1578, 10.1086/379230 Sawai, 2007, Growth phase-dependent effect of clindamycin on production of exoproteins by Streptococcus pyogenes, Antimicrob Agents Chemother, 51, 461, 10.1128/AAC.00539-06 Bingen, 2004, Emergence of macrolide-resistant Streptococcus pyogenes strains in French children, Antimicrob Agents Chemother, 48, 3559, 10.1128/AAC.48.9.3559-3562.2004 Martin, 2002, Erythromycin-resistant group A streptococci in schoolchildren in Pittsburgh, N Engl J Med, 346, 1200, 10.1056/NEJMoa013169 Garcia-Rey, 2002, Pharmacoepi-demiological analysis of provincial differences between consumption of macrolides and rates of erythromycin resistance among Streptococcus pyogenes isolates in Spain, J Clin Microbiol, 40, 2959, 10.1128/JCM.40.8.2959-2963.2002 Jasir, 1998, Survey of macrolide resistance phenotypes in Swedish clinical isolates of Streptococcus pyogenes, J Antimicrob Chemother, 41, 135, 10.1093/jac/41.1.135 Mihaila-Amrouche, 2004, Clonal spread of emm type 28 isolates of Streptococcus pyogenes that are multiresistant to antibiotics, J Clin Microbiol, 42, 3844, 10.1128/JCM.42.8.3844-3846.2004 Chen, 2011, Emergence of erythromycin- and clindamycin-resistant Streptococcus pyogenes emm 90 strains in Hawaii, J Clin Microbiol, 49, 439, 10.1128/JCM.02208-10 1993, Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition, JAMA, 269, 390, 10.1001/jama.1993.03500030088038 Chatellier, 2000, Genetic relatedness and superantigen expression in group A streptococcus serotype Ml isolates from patients with severe and nonsevere invasive diseases, Infect Immun, 68, 3523, 10.1128/IAI.68.6.3523-3534.2000 Tyler, 1992, Streptococcal erythrogenic toxin genes: detection by polymerase chain reaction and association with disease in strains isolated in Canada from 1940 to 1991, J Clin Microbiol, 30, 3127, 10.1128/JCM.30.12.3127-3131.1992 Malhotra-Kumar, 2005, Multiplex PCR for simultaneous detection of macrolide and tetracycline resistance determinants in streptococci, Antimicrob Agents Chemother, 49, 4798, 10.1128/AAC.49.11.4798-4800.2005 Lamagni, 2008, Epidemiology of severe Streptococcus pyogenes disease in Europe, J Clin Microbiol, 46, 2359, 10.1128/JCM.00422-08 O'Loughlin, 2007, The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004, Clin Infect Dis, 45, 853, 10.1086/521264 Lamagni, 2008, Severe Streptococcus pyogenes infections, United Kingdom, 2003-2004, Emerg Infect Dis, 14, 202, 10.3201/eid1402.070888 Darenberg, 2007, Molecular and clinical characteristics of invasive group A streptococcal infection in Sweden, Clin Infect Dis, 45, 450, 10.1086/519936 Meisal, 2010, Streptococcus pyogenes isolates causing severe infections in Norway in 2006 to 2007: emm types, multilocus sequence types, and superantigen profiles, J Clin Microbiol, 48, 842, 10.1128/JCM.01312-09 O'Brien, 2002, Epidemiology of invasive group a Streptococcus disease in the United States, 1995-1999, Clin Infect Dis, 35, 268, 10.1086/341409 Ikebe, 2007, Distribution of emm genotypes among group a streptococcus isolates from patients with severe invasive streptococcal infections in Japan, 2001-2005, Epidemiol Infect, 135, 1227, 10.1017/S0950268807007984 Luca-Harari, 2009, Clinical and microbiological characteristics of severe Streptococcus pyogenes disease in Europe, J Clin Microbiol, 47, 1155, 10.1128/JCM.02155-08 Wahl, 2007, Epidemiology of invasive Streptococcus pyogenes infections in Germany, 1996-2002: results from a voluntary laboratory surveillance system, Clin Microbiol Infect, 13, 1173, 10.1111/j.1469-0691.2007.01821.x Bouvet, 2004, Emergence de la résistance aux macrolides des Streptococcus pyogenes ou streptocoques bêta-hémoly-tiques du groupe A, Bull Epidémiol Hebd, 32-33, 154 Ardanuy, 2010, Molecular characterization of macrolide- and multidrug-resistant Streptococcus pyogenes isolated from adult patients in Barcelona, Spain (1993-2008), J Antimicrob Chemother, 65, 634, 10.1093/jac/dkq006 Perez-Trallero, 2010, Antimicrobial resistance among respiratory pathogens in Spain: latest data and changes over 11 years (1996-1997 to 2006-2007), Antimicrob Agents Chemother, 54, 2953, 10.1128/AAC.01548-09 Silva-Costa, 2008, Decrease in macrolide resistance and clonal instability among Streptococcus pyogenes in Portugal, Clin Microbiol Infect, 14, 1152, 10.1111/j.1469-0691.2008.02104.x Sabuncu, 2009, Significant reduction of antibiotic use in the community after a nationwide campaign in France, 2002-2007, PLoS Med, 6, e1000084, 10.1371/journal.pmed.1000084 Malhotra-Kumar, 2005, Macrolide- and telithromycin-resistant Streptococcus pyogenes, Belgium, 1999-2003, Emerg Infect Dis, 11, 939, 10.3201/eid1106.041247 Creti, 2007, emm types, virulence factors, and antibiotic resistance of invasive Streptococcus pyogenes isolates from Italy: what has changed in 11 years?, J Clin Microbiol, 45, 2249, 10.1128/JCM.00513-07 Reinert, 2004, Molecular characterisation of macrolide resistance mechanisms of Streptococcus pneumoniae and Streptococcus pyogenes isolated in Germany, 2002-2003, Int J Antimicrob Agents, 24, 43, 10.1016/j.ijantimicag.2004.02.020 Imohl, 2010, Epidemiology of invasive Streptococcus pyogenes disease in Germany during 2003-2007, FEMS Immunol Med Microbiol, 58, 389, 10.1111/j.1574-695X.2010.00652.x Montes, 2010, Prevalence and clonal characterization of Streptococcus pyogenes clinical isolates with reduced fluoroquinolone susceptibility in Spain, Antimicrob Agents Chemother, 54, 93, 10.1128/AAC.00780-09 Alonso, 2005, Clonal spread of pediatric isolates of ciprofloxacin-resistant, emm type 6 Streptococcus pyogenes, J Clin Microbiol, 43, 2492, 10.1128/JCM.43.5.2492-2493.2005